Guanze Medical要约截止富德香港持股73.6% 公众持股比例达标

公告速递

May 08

富德（香港）投资控股有限公司（要约人）与Guanze Medical Information Industry (Holding) Co., Ltd.（Guanze Medical，股票代码02427）联合公告，要约人提出的强制性无条件现金要约已于2026年5月8日下午四时正截止，且未作修订或延长。

公告显示，截至要约截止时间，要约人共接获两份有效接纳，涉及10,000股Guanze Medical股份，占公司已发行股本总额约0.001%。经此，要约人及其最终实益拥有人、一致行动人士合共持有699,174,575股股份，占公司已发行股本总额约73.6%。

根据每股0.25港元的要约价，上述有效接纳涉及的总代价为2500港元。要约人将在收到完整有效文件后的7个营业日内，以平邮方式向接纳要约的独立股东寄发应付现金代价（扣除卖方从价印花税后），寄发股款的最后日期为2026年5月19日。

股权结构方面，紧接要约截止后，公众人士持有Guanze Medical 250,825,425股股份，占已发行股本总额约26.4%，符合上市规则第13.32B(1)条关于25%最低公众持股量的要求。

据悉，要约人由张先生及陶女士最终实益拥有94%及6%股权。此前，要约人已通过买卖协议收购Meng A Capital Limited持有的699,164,575股股份，占公司已发行股本73.6%。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1134774889"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1134774889\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1134774889?lang=en_US&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2026-05-08 19:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1134774889","market":"sh","top_or_hot":-1,"title":"Guanze Medical要约截止 富德香港持股73.6% 公众持股比例达标","media":"公告速递","content":"<p>富德（香港）投资控股有限公司（要约人）与Guanze Medical Information Industry (Holding) Co., Ltd.（Guanze Medical，股票代码02427）联合公告，要约人提出的强制性无条件现金要约已于2026年5月8日下午四时正截止，且未作修订或延长。</p>\n<p>公告显示，截至要约截止时间，要约人共接获两份有效接纳，涉及10,000股Guanze Medical股份，占公司已发行股本总额约0.001%。经此，要约人及其最终实益拥有人、一致行动人士合共持有699,174,575股股份，占公司已发行股本总额约73.6%。</p>\n<p>根据每股0.25港元的要约价，上述有效接纳涉及的总代价为2500港元。要约人将在收到完整有效文件后的7个营业日内，以平邮方式向接纳要约的独立股东寄发应付现金代价（扣除卖方从价印花税后），寄发股款的最后日期为2026年5月19日。</p>\n<p>股权结构方面，紧接要约截止后，公众人士持有Guanze Medical 250,825,425股股份，占已发行股本总额约26.4%，符合上市规则第13.32B(1)条关于25%最低公众持股量的要求。</p>\n<p>据悉，要约人由张先生及陶女士最终实益拥有94%及6%股权。此前，要约人已通过买卖协议收购Meng A Capital Limited持有的699,164,575股股份，占公司已发行股本73.6%。</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Guanze Medical要约截止 富德香港持股73.6% 公众持股比例达标</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGuanze Medical要约截止 富德香港持股73.6% 公众持股比例达标\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1097772564\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">公告速递 </p>\n<p class=\"h-time\">2026-05-08 19:16</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>富德（香港）投资控股有限公司（要约人）与Guanze Medical Information Industry (Holding) Co., Ltd.（Guanze Medical，股票代码02427）联合公告，要约人提出的强制性无条件现金要约已于2026年5月8日下午四时正截止，且未作修订或延长。</p>\n<p>公告显示，截至要约截止时间，要约人共接获两份有效接纳，涉及10,000股Guanze Medical股份，占公司已发行股本总额约0.001%。经此，要约人及其最终实益拥有人、一致行动人士合共持有699,174,575股股份，占公司已发行股本总额约73.6%。</p>\n<p>根据每股0.25港元的要约价，上述有效接纳涉及的总代价为2500港元。要约人将在收到完整有效文件后的7个营业日内，以平邮方式向接纳要约的独立股东寄发应付现金代价（扣除卖方从价印花税后），寄发股款的最后日期为2026年5月19日。</p>\n<p>股权结构方面，紧接要约截止后，公众人士持有Guanze Medical 250,825,425股股份，占已发行股本总额约26.4%，符合上市规则第13.32B(1)条关于25%最低公众持股量的要求。</p>\n<p>据悉，要约人由张先生及陶女士最终实益拥有94%及6%股权。此前，要约人已通过买卖协议收购Meng A Capital Limited持有的699,164,575股股份，占公司已发行股本73.6%。</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02427","symbol_name":"GUANZE MEDICAL","start_time":0,"source_url":"","article_id":"1134774889","we_media_id":"1097772564","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1134774889","pubTimestamp":1778238980,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"公告速递","introduction":"港美股公告全覆盖","home_visible":1,"id":"1097772564","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"富德（香港）投资控股有限公司（要约人）与Guanze Medical Information Industry  Co., Ltd.联合公告，要约人提出的强制性无条件现金要约已于2026年5月8日下午四时正截止，且未作修订或延长。公告显示，截至要约截止时间，要约人共接获两份有效接纳，涉及10,000股Guanze Medical股份，占公司已发行股本总额约0.001%。据悉，要约人由张先生及陶女士最终实益拥有94%及6%股权。此前，要约人已通过买卖协议收购Meng A Capital Limited持有的699,164,575股股份，占公司已发行股本73.6%。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"02427":"GUANZE MEDICAL"},"translate_title":"Guanze Medical's offer closes, Fude Hong Kong holds 73.6% of the shares, and the public shareholding ratio meets the standard","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02427":1},"content_text":"富德（香港）投资控股有限公司（要约人）与Guanze Medical Information Industry (Holding) Co., Ltd.（Guanze Medical，股票代码02427）联合公告，要约人提出的强制性无条件现金要约已于2026年5月8日下午四时正截止，且未作修订或延长。\n公告显示，截至要约截止时间，要约人共接获两份有效接纳，涉及10,000股Guanze Medical股份，占公司已发行股本总额约0.001%。经此，要约人及其最终实益拥有人、一致行动人士合共持有699,174,575股股份，占公司已发行股本总额约73.6%。\n根据每股0.25港元的要约价，上述有效接纳涉及的总代价为2500港元。要约人将在收到完整有效文件后的7个营业日内，以平邮方式向接纳要约的独立股东寄发应付现金代价（扣除卖方从价印花税后），寄发股款的最后日期为2026年5月19日。\n股权结构方面，紧接要约截止后，公众人士持有Guanze Medical 250,825,425股股份，占已发行股本总额约26.4%，符合上市规则第13.32B(1)条关于25%最低公众持股量的要求。\n据悉，要约人由张先生及陶女士最终实益拥有94%及6%股权。此前，要约人已通过买卖协议收购Meng A Capital Limited持有的699,164,575股股份，占公司已发行股本73.6%。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}